OCYON Eleven PR New Tech HUB

PUERTO RICO

• 60-year history in pharmaceutical manufacturing,
• Exports more than $5B monthly
• Graduates more than 20,000 STEM undergraduates more than any other state.
• Produces top 20 pharmaceutical products in the world
• Amgen, Pfizer, Abvvie, Medtronics, Boston Scientific, Merck, and others are here
• 50% federally backed non-dilutive refund for R & D
• 4% taxes on profits
• THE NEXT STEP is to Create a Biotech and Pharmaceutical Hub to support R & D to commercialization and re-imagine the CDMO model to support biotech and gene and cell therapy companies without the deficiencies of the current CDMO model.

PUERTO RICO TECHNOLOGY HUB - OCYON ELEVEN

Experience the next generation of Contract Development and Manufacturing Organization (CDMO) with our innovative Partnership Development and Manufacturing Organization (PDMO) model. PDMO unlocks CDMO 2.0 by empowering companies to thrive within the HUB infrastructure. Harness the power of our existing R&D, clinical, and commercial manufacturing spaces, and operate autonomously in your selected or pre-designed clean rooms or facilities. Enjoy the flexibility, efficiency, and control to drive your projects forward while leveraging the collaborative advantages of the HUB environment. PDMO revolutionizes the way you think about CDMO, unlocking new opportunities for success in the biotechnology industry. OCYON ELEVEN currently has over 200,000 sqft and the final technology hub will have in excess of 1 million sqft of space to create homes for biotech, viral mfg, gene and cell therapy, clinical research from early R & D to commercialization. We are opening an OCYON of possibilities.

CDMO 2.0 = PDMO (Partnership Development Management Organization)

PDMO Overcomes CDMO Deficiencies

Collaboration has become the cornerstone of progress in the competitive realm of biotechnology. Recognizing the need for a dynamic and flexible approach, Ocyonbio pioneered the partnership development organization (PDMO) model, revolutionizing how companies innovate and bring their products to market. Unlike the traditional CDMO model, which often requires relinquishing control and intellectual property, the PDMO model empowers companies to operate autonomously within Ocyonbio's campus.

COLLABORATION IS KEY TO SUCCESS

Unlike many CDMOs maintain a transactional approach, limiting the opportunity for meaningful collaboration between companies and the CDMO's scientific and technical teams. Ocyonbio embraces teamwork as a core principle of their PDMO model. Their talented workforce, comprising scientists, technicians, and support staff, actively engages with partner companies, providing expertise, guidance, and a shared commitment to success. This collaborative culture fosters a vibrant community of innovators, creating an environment where ideas thrive, and partnerships flourish.

PROTECTING YOUR IP

At Ocyonbio, we value protecting intellectual property as crucial to maintaining a competitive edge. That's why we provide dedicated space within our cutting-edge facilities, allowing companies to retain complete control over their research, development, and manufacturing processes. This distinctive approach ensures the safeguarding of valuable IP, enabling companies to freely explore their pipeline and introduce products to the market without the drawbacks commonly associated with traditional CDMOs. Unlike CDMOs, where ?IP cannot be shared, knowledge gained from projects can be utilized to benefit other programs; we believe in preserving your exclusivity and preventing your competitors from gaining an advantage through technology transfers. We understand the importance of maintaining a level playing field and ensuring that your hard work focuses solely on advancing your timelines and success.

FEDERALLY BACKED NON-DILUTIVE FUNDING

Moreover, partnering with Ocyonbio in Puerto Rico offers additional advantages due to the unique incentives and resources available on the island. Puerto Rico has established a robust incentive program to attract and support research and development (R&D) activities. Under these incentives, companies engaged in R&D can receive a 50% annual refund based on their qualified expenses for up to 15 years. This substantial refund provides a significant financial advantage, allowing companies to allocate more resources toward innovation and accelerate their progress.

Furthermore, companies benefit from a highly favorable tax environment when they become profitable. Puerto Rico offers a reduced corporate tax rate of only 4% for qualifying businesses engaged in manufacturing and R&D activities. This advantageous tax structure incentivizes companies to establish a presence in Puerto Rico, fostering economic growth and innovation.

20,000 STEM GRADUATES AVAILABLE ANNUALLY

In addition to the incentives, Puerto Rico boasts a unique educational ecosystem. With over 80 universities and post-high school training centers, the island produces a highly skilled and diverse talent pool. Puerto Rico's educational institutions graduate over 20,000 students in science, technology, engineering, and mathematics (STEM) disciplines, surpassing any other state in the United States. This abundance of talented individuals provides a rich resource for companies partnering with Ocyonbio, ensuring access to top-notch professionals who can contribute to groundbreaking research and development efforts. Puerto Ricans speak three languages English, Spanish and cGMP with local FDA office to ensure Made in USA Gold Standard.

MADE IN USA

Notably, Puerto Rico has established itself as a leading player in the pharmaceutical industry. The island is the largest exporter of pharmaceutical products in the United States, with monthly exports exceeding $5 billion. Additionally, Puerto Rico is home to over 20 pharmaceutical manufacturing facilities, producing a diverse range of life-saving medications. This strong presence in the pharmaceutical industry further solidifies Puerto Rico's position as a prime location for biotechnology partnerships.

ACCELERATION OF PIPELINE

Ocyonbio's partnership development organization (PDMO) model, coupled with the unique incentives and resources available in Puerto Rico, offers an unparalleled opportunity for companies in the biotechnology sector. The autonomy to operate within Ocyonbio's facilities and the ability to protect intellectual property provides companies with the freedom and control necessary for innovation. Moreover, the generous incentives offered by Puerto Rico, including the R&D expense refund and reduced tax rate, further enhance the attractiveness of partnering with Ocyonbio. With Puerto Rico's robust educational ecosystem, talented workforce, and thriving pharmaceutical industry, companies can unlock their full potential and thrive in the dynamic world of biotechnology.

In conclusion, Ocyonbio, with its groundbreaking Ocyon Eleven Technology HUB creates PDMO and is your ideal partner for facility and process development. We offer readily available space within our campus, eliminating the need for substantial capital investment. By leveraging our interconnected infrastructure, including warehouses, laboratories, blood processing facilities, viral vector manufacturing capabilities, and release and in-process testing capabilities, you can streamline your operations and maximize efficiency. Our comprehensive approach ensures a seamless integration of your facility within our campus, allowing you to focus on your core activities while benefiting from the shared resources and expertise. Trust Ocyonbio to bring your vision to life and propel your biotechnology endeavors to new heights.

As always please connect with us in LinkedIn page or contact me directly to get more information. [email protected]